RIO DE JANEIRO, Nov. 23, 2010 /PRNewswire/ -- Amilpar (BM&FBovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3 SA), the largest healthcare company in Brazil, in accordance with CVM Instruction 358/02, informs that its controlling shareholders sold 2.9% of common shares of the Company's capital stock through an auction at BM&FBovespa.
The main objective of this offer was to raise the shares free float in the market, considering the strong demand in the last few weeks due to the inclusion of the Company in the MSCI Brazil Standard index. Before the offer, the percentage of shares in free float was 27.7% and, as of now, will become 30.6%.
After the offer, the controlling shareholders had a participation of 66.8% of Amilpar's total capital, therefore nothing changes in terms of management and long-term goals.
To access the .pdf full version of the document, visit our website at http://www.amilpar.com.br/ir
IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 invest@amil.com.br http://www.amilpar.com.br/ir About Amilpar
Amil Participacoes S.A. is the largest healthcare company in Brazil, according to the ANS, currently assisting over 5 million members in the states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco, Bahia, Rio Grande do Norte and in Distrito Federal. It is also the managed care organization with the largest provider network in the country, including over (i) 3,600 hospitals; (ii) 62,000 polyclinics and outpatient facilities; and (iii) 11,200 laboratories and diagnostic imaging centers. Amil began its activities in 1978 and offers a wide range of healthcare plans for small, medium and large companies, as well as plans for individuals from all income segments, offering its members access to carefully selected healthcare service providers.
Amilpar
CONTACT: IR Contact, Erwin Kleuser, Investor Relations Officer, Amilpar,
+011-55-21-3805-1155, invest@amil.com.br
Web Site: http://www.amilpar.com.br/ir
